HardwareWarwick, United KingdomFounded 2006· One of 1708 Hardware companies tracked by AMPulse
Designs, manufactures, and supports high-precision automation equipment for pharmaceutical and industrial manufacturing, from lab-scale to commercial scale.
CEO / Founder
Nick Brooks
Team Size
51-200
Stage
Active
Total Funding
$6.6M
Latest Round
Venture Round
Technology & Products
Key Products
Aseptic fill-finish systems (liquid and powder), custom automation solutions, and specialized equipment for pharmaceutical and medical device manufacturing, including next-generation DPI (Dry Powder Inhaler) filling technology.
Technological Advantage
Proprietary gravimetric powder filling technology achieving high-accuracy dosing in sterile environments; employee ownership model driving innovation and client service excellence; recognized with Queen's Awards for Innovation and International Trade.
Differentiation
Value Proposition
Reduces development risk and accelerates time-to-market through proof-of-principle validation and rapid issue resolution, enabling clients to innovate with confidence in stringent environments.
How They Differentiate
Focus on pharmaceutical automation with proprietary powder handling vs. general AM hardware; employee-owned model vs. venture-backed competitors; deep expertise in aseptic environments vs. broader industrial automation.
Market & Competition
Target Customers
Pharmaceutical, medical device, and FMCG manufacturers requiring precision automation for aseptic fill/finish and powder handling.
Industry Verticals
Pharmaceutical; Medical Device; FMCG; Confectionery
Revenue £13.64 million (approx $17.3M USD) for period ending 31 July 2024; team size ~95 employees as of July 2024; invested £5 million in new facility.
Major Milestones
Founded in 2006; Transitioned to employee ownership in 2020; Won Queen's Award for Innovation and International Trade; Launched R500 robotic filler in 2016; Secured £5 million facility investment
3P Innovation occupies a narrow but defensible niche: high-precision automation equipment for aseptic fill-finish and powder handling in pharmaceutical and medical device production. Unlike general industrial automation providers, the company focuses on sterile environments where dosing accuracy and contamination control are critical. Its employee-owned structure, adopted in 2020, is intended to align long-term incentives with quality and client retention, a contrast to the venture-capital-backed growth model common among additive manufacturing hardware firms.
The company's core technological advantage is proprietary gravimetric powder micro-dosing technology, which enables high-accuracy filling of dry powder inhalers and other sterile dosage forms. Its product line includes aseptic liquid and powder fill-finish systems, custom automation solutions, and the R500 robotic filler launched in 2016. The '3P' methodology—Product, Process, Production—integrates manufacturing constraints early in development, reducing risk for clients moving from lab-scale to commercial production.
Target customers include pharmaceutical, medical device, and FMCG manufacturers that require precision automation for aseptic processes. Named client Upperton Pharma Solutions reflects the company's focus on contract development and manufacturing organizations. Partnerships with Stäubli Robotics and Cellular Origins extend its automation capabilities. With revenue of approximately £13.6 million ($17.3M) for the period ending July 2024 and a team of about 95 employees, 3P Innovation has invested £5 million in a new facility to support growth.
The company's strategic moat rests on deep expertise in sterile powder handling and a track record recognized by Queen's Awards for Innovation and International Trade. However, its narrow vertical focus limits total addressable market compared to broader industrial automation players. The employee-ownership model may constrain rapid scaling, but it also reduces the pressure to chase volume over margin—a trade-off that suits a specialist serving regulated industries.
Competitive Intelligence
Competitors, SWOT analysis, and investment insights